Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$7.06 - $13.97 $99,976 - $197,829
-14,161 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$12.15 - $35.28 $11,214 - $32,563
923 Added 6.97%
14,161 $172,000
Q4 2021

Jan 31, 2022

SELL
$30.49 - $48.49 $8,293 - $13,189
-272 Reduced 2.01%
13,238 $451,000
Q3 2021

Oct 29, 2021

BUY
$41.66 - $52.52 $230,088 - $290,067
5,523 Added 69.15%
13,510 $651,000
Q2 2021

Aug 11, 2021

BUY
$36.62 - $51.69 $12,047 - $17,006
329 Added 4.3%
7,987 $360,000
Q1 2021

May 04, 2021

SELL
$41.56 - $59.88 $789 - $1,137
-19 Reduced 0.25%
7,658 $369,000
Q4 2020

Feb 11, 2021

SELL
$36.08 - $56.47 $851,524 - $1.33 Million
-23,601 Reduced 75.46%
7,677 $413,000
Q3 2020

Nov 05, 2020

SELL
$33.26 - $40.48 $15,731 - $19,147
-473 Reduced 1.49%
31,278 $1.15 Million
Q2 2020

Aug 12, 2020

BUY
$24.21 - $31.02 $20,239 - $25,932
836 Added 2.7%
31,751 $983,000
Q1 2020

May 11, 2020

BUY
$20.5 - $34.53 $26,896 - $45,303
1,312 Added 4.43%
30,915 $853,000
Q4 2019

Feb 05, 2020

SELL
$18.96 - $29.84 $33,180 - $52,220
-1,750 Reduced 5.58%
29,603 $865,000
Q3 2019

Oct 30, 2019

BUY
$19.12 - $26.24 $109,098 - $149,725
5,706 Added 22.25%
31,353 $599,000
Q2 2019

Jul 19, 2019

BUY
$19.57 - $24.1 $18,493 - $22,774
945 Added 3.83%
25,647 $562,000
Q1 2019

May 13, 2019

BUY
$12.14 - $20.46 $2,695 - $4,542
222 Added 0.91%
24,702 $505,000
Q4 2018

Feb 11, 2019

BUY
$11.24 - $18.5 $2,023 - $3,330
180 Added 0.74%
24,480 $308,000
Q3 2018

Nov 06, 2018

BUY
$12.5 - $15.38 $88,750 - $109,198
7,100 Added 41.28%
24,300 $373,000
Q4 2017

Feb 12, 2018

BUY
$8.02 - $11.18 $137,944 - $192,296
17,200
17,200 $152,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.08B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.